Cargando…

A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals

PURPOSE: To develop a model of the internal vasculature of the adult liver and demonstrate its application to the differentiation of radiopharmaceutical decay sites within liver parenchyma from those within organ blood. METHOD: Computer-generated models of hepatic arterial (HA), hepatic venous (HV),...

Descripción completa

Detalles Bibliográficos
Autores principales: Correa-Alfonso, Camilo M., Withrow, Julia D., Domal, Sean J., Xing, Shu, Shin, Jungwook, Grassberger, Clemens, Paganetti, Harald, Bolch, Wesley E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008118/
https://www.ncbi.nlm.nih.gov/pubmed/35416550
http://dx.doi.org/10.1186/s40658-022-00456-0
_version_ 1784686977454440448
author Correa-Alfonso, Camilo M.
Withrow, Julia D.
Domal, Sean J.
Xing, Shu
Shin, Jungwook
Grassberger, Clemens
Paganetti, Harald
Bolch, Wesley E.
author_facet Correa-Alfonso, Camilo M.
Withrow, Julia D.
Domal, Sean J.
Xing, Shu
Shin, Jungwook
Grassberger, Clemens
Paganetti, Harald
Bolch, Wesley E.
author_sort Correa-Alfonso, Camilo M.
collection PubMed
description PURPOSE: To develop a model of the internal vasculature of the adult liver and demonstrate its application to the differentiation of radiopharmaceutical decay sites within liver parenchyma from those within organ blood. METHOD: Computer-generated models of hepatic arterial (HA), hepatic venous (HV), and hepatic portal venous (HPV) vascular trees were algorithmically created within individual lobes of the ICRP adult female and male livers (AFL/AML). For each iteration of the algorithm, pressure, blood flow, and vessel radii within each tree were updated as each new vessel was created and connected to a viable bifurcation site. The vascular networks created inside the AFL/AML were then tetrahedralized for coupling to the PHITS radiation transport code. Specific absorbed fractions (SAF) were computed for monoenergetic alpha particles, electrons, positrons, and photons. Dual-region liver models of the AFL/AML were proposed, and particle-specific SAF values were computed assuming radionuclide decays in blood within two locations: (1) sites within explicitly modeled hepatic vessels, and (2) sites within the hepatic blood pool residing outside these vessels to include the capillaries and blood sinuses. S values for 22 and 10 radionuclides commonly used in radiopharmaceutical therapy and imaging, respectively, were computed using the dual-region liver models and compared to those obtained in the existing single-region liver model. RESULTS: Liver models with virtual vasculatures of ~ 6000 non-intersecting straight cylinders representing the HA, HPV, and HV circulations were created for the ICRP reference. For alpha emitters and for beta and auger-electron emitters, S values using the single-region models were approximately 11% (AML) to 14% (AFL) and 11% (AML) to 13% (AFL) higher than the S values obtained using the dual-region models, respectively. CONCLUSIONS: The methodology employed in this study has shown improvements in organ parenchymal dosimetry through explicit consideration of blood self-dose for alpha particles (all energies) and for electrons at energies below ~ 100 keV.
format Online
Article
Text
id pubmed-9008118
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-90081182022-04-27 A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals Correa-Alfonso, Camilo M. Withrow, Julia D. Domal, Sean J. Xing, Shu Shin, Jungwook Grassberger, Clemens Paganetti, Harald Bolch, Wesley E. EJNMMI Phys Original Research PURPOSE: To develop a model of the internal vasculature of the adult liver and demonstrate its application to the differentiation of radiopharmaceutical decay sites within liver parenchyma from those within organ blood. METHOD: Computer-generated models of hepatic arterial (HA), hepatic venous (HV), and hepatic portal venous (HPV) vascular trees were algorithmically created within individual lobes of the ICRP adult female and male livers (AFL/AML). For each iteration of the algorithm, pressure, blood flow, and vessel radii within each tree were updated as each new vessel was created and connected to a viable bifurcation site. The vascular networks created inside the AFL/AML were then tetrahedralized for coupling to the PHITS radiation transport code. Specific absorbed fractions (SAF) were computed for monoenergetic alpha particles, electrons, positrons, and photons. Dual-region liver models of the AFL/AML were proposed, and particle-specific SAF values were computed assuming radionuclide decays in blood within two locations: (1) sites within explicitly modeled hepatic vessels, and (2) sites within the hepatic blood pool residing outside these vessels to include the capillaries and blood sinuses. S values for 22 and 10 radionuclides commonly used in radiopharmaceutical therapy and imaging, respectively, were computed using the dual-region liver models and compared to those obtained in the existing single-region liver model. RESULTS: Liver models with virtual vasculatures of ~ 6000 non-intersecting straight cylinders representing the HA, HPV, and HV circulations were created for the ICRP reference. For alpha emitters and for beta and auger-electron emitters, S values using the single-region models were approximately 11% (AML) to 14% (AFL) and 11% (AML) to 13% (AFL) higher than the S values obtained using the dual-region models, respectively. CONCLUSIONS: The methodology employed in this study has shown improvements in organ parenchymal dosimetry through explicit consideration of blood self-dose for alpha particles (all energies) and for electrons at energies below ~ 100 keV. Springer International Publishing 2022-04-13 /pmc/articles/PMC9008118/ /pubmed/35416550 http://dx.doi.org/10.1186/s40658-022-00456-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
Correa-Alfonso, Camilo M.
Withrow, Julia D.
Domal, Sean J.
Xing, Shu
Shin, Jungwook
Grassberger, Clemens
Paganetti, Harald
Bolch, Wesley E.
A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals
title A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals
title_full A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals
title_fullStr A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals
title_full_unstemmed A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals
title_short A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals
title_sort mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008118/
https://www.ncbi.nlm.nih.gov/pubmed/35416550
http://dx.doi.org/10.1186/s40658-022-00456-0
work_keys_str_mv AT correaalfonsocamilom ameshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT withrowjuliad ameshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT domalseanj ameshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT xingshu ameshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT shinjungwook ameshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT grassbergerclemens ameshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT paganettiharald ameshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT bolchwesleye ameshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT correaalfonsocamilom meshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT withrowjuliad meshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT domalseanj meshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT xingshu meshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT shinjungwook meshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT grassbergerclemens meshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT paganettiharald meshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals
AT bolchwesleye meshbasedmodeloflivervasculatureimplicationsforimprovedradiationdosimetrytoliverparenchymaforradiopharmaceuticals